30
- Categories
- Satellite Symposium
- Satellite Symposium
- Satellite Symposium
Advancing treatment for ES-SCLC: innovations in precision medicine
-
,
Delhi
Endorsed by: Amgen
-
The evolving treatment landscape of ES-SCLC
-
DLL3-targeted T-cell engagers: A novel approach to treating recurrent ES-SCLC
Speaker: Martin Früh (HOCH Health Ostschweiz)
-
Clinical management of patients receiving DLL3 T-cell engager immunotherapy
-
Emerging opportunities for first-line treatment of ES-SCLC